Illinois CancerCare-Peru — Peru, Illinois

Illinois CancerCare-Peru is a clinical research site located in Peru, Illinois, United States 61354.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Illinois CancerCare-Peru has participated in 374 clinical trials with 242 currently active.

Therapeutic areas: Ovarian Granulosa Cell Tumor, Ovarian Gynandroblastoma, Ovarian Sertoli-Leydig Cell Tumor.

Sponsors: GOG Foundation, SWOG Cancer Research Network, National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Illinois CancerCare-Peru?

Illinois CancerCare-Peru has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Illinois CancerCare-Peru conducted?

Illinois CancerCare-Peru has 374 clinical trials on record, with 242 currently active. Their work covers Ovarian Granulosa Cell Tumor, Ovarian Gynandroblastoma, Ovarian Sertoli-Leydig Cell Tumor.

Is Illinois CancerCare-Peru accredited by Crixeo Health?

Illinois CancerCare-Peru has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Illinois CancerCare-Peru?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.